Phase I Trial of Image Guided Focally Dose Escalated Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy
Latest Information Update: 17 Jun 2025
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions
Most Recent Events
- 11 Jun 2025 Status changed from active, no longer recruiting to completed.
- 10 Aug 2023 Planned End Date changed from 20 Dec 2028 to 16 Feb 2025.
- 10 Aug 2023 Status changed from recruiting to active, no longer recruiting.